Sept 16 (Reuters) – Abbott Laboratories said it
would sell its eye care business to Johnson & Johnson
for about $4.33 billion in cash to focus on cardiovascular
devices and diagnostics business.
The post UPDATE 2-Abbott to sell its eye care business to J&J for about $4.33 bln appeared first on NASDAQ.